US Portal Opportunity Integrum recently launched a digital patient portal in the United States to boost patient flow and awareness of the OPRA Implant System. This presents a potential cross-sell to healthcare providers and clinics serving amputees, offering integration support, data insights, and user training services to maximize adoption and engagement.

Global Clinical Reach With a world-leading position in osseointegration and treatment centers of excellence worldwide, there is a strong opportunity to expand partnerships, distribution, and training programs with international clinics, hospitals, and academic centers seeking premium bone-anchored solutions.

Regulatory Stronghold The OPRA Implant System is FDA-approved and is uniquely designed for amputees in the U.S., underscoring reliability and market access. This opens sales channels for device suppliers, service contracts, and regulatory consulting support for clinics expanding to or upgrading osseointegration programs.

Strategic Hiring New appointment to coordinate commercial activities in Ukraine signals regional expansion and channel development opportunities. There is potential to partner on distributor networks, training services, and localized clinical support in Eastern Europe.

Capitalize on Funding With moderate revenue and available funding, Integrum can scale commercial operations, accelerate clinical education programs, and invest in digital patient engagement tools for physicians and patients, creating upsell paths for service bundles and extended maintenance of implant systems.